DOCSLIB.ORG

Biomedical Engineering (BME)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biomedical Engineering (BME) COURSE DESCRIPTIONS Spring 2006: updates since Spring 2005 are in red dominates behavior. Presents the physiological mechanisms of nanofabrication with emphasis on cut- effects of mechanical stresses on organs, pathologies ting-edge discovery to overcome current challenges BME that develop from abnormal stress, and how biologi- associated with nanofabricated machines. cal growth and adaptation arise as a natural response Prerequisites: CHE 132 and BME 305 Biomedical Engineering to the mechanics of living. Pre- or Corequisite: BIO 202 or 203 Prerequisites: MEC 260; BIO 202 or 203; ESG 111 3 credits (or CSE 130 or ESE 124 or MEC 111 or MEC 112); BME 100 Introduction to Biomedical BME 212 BME 404 Essentials of Tissue Engineering Engineering 3 credits Topics covered are developmental biology (nature’s An introduction to and overview of biomedical engi- tissue engineering), mechanisms of cell and cell- neering. Selected topics review state-of-the-art bio- BME 304-H Genetic Engineering matrix interactions, biomaterial formulation, charac- engineering developments in solving medical prob- An introduction to the realm of molecular bioengi- terization of biomaterial properties, evaluation of cell lems as well as the identification of clinical and health neering with a focus on genetic engineering. Includes interactions with biomaterials, principles of designing problems and their engineering solutions. Includes the structure and function of DNA, the flow of genetic an engineered tissue. Considers manufacturing para- the roles of biotechnology and biomedical engineers information in a cell, genetic mechanisms, the meters such as time, rate, cost, efficiency, safety, and in supporting global human well-being. methodology involved in recombinant DNA technolo- desired product quality as well as regulatory issues. 3 credits gy and its application in society in terms of cloning and Prerequisites: BIO 202 or 203; CHE 132 genetic modification of plants and animals (transgen- Advisory prerequisites: CHE 321 and 322 BME 201-H Biomedical Engineering and ics), biotechnology (pharmaceutics, genomics), bio- 3 credits Society processing (production and process engineering How engineers interact with others in the develop- focusing on the production of genetically engineered BME 420 Computational Biomechanics ment of solutions to societal problems, with emphasis products.), and gene therapy. Production factors such Introduces the concepts of skeletal biology; mechan- on engineering problems arising in the biological as time, rate, cost, efficiency, safety, and desired prod- ics of bone, ligament, and tendon; and linear and non- realm. In-depth evaluations of both successful and uct quality are also covered. Considers societal issues linear properties of biological tissues. Principles of unsuccessful technologies illuminate the role of bio- involving ethical and moral considerations, conse- finite differences method (FDM) and finite elements medical engineers in supporting the well-being of quences of regulation, as well as risks and benefits of method (FEM) to solve biological problems. Both urban and rural populations throughout the world, genetic engineering. FDM and FEM are applied to solve equations and through developments in medical engineering, Prerequisites: BME 100; BIO 202 or 203 problems in solid and porous media. Requires knowl- biotechnology, environmental engineering, and 3 credits edge of Fortran or C programming. ergonomic design. Not for credit in addition to Prerequisites: BME 303; BME 305; MEC 363 BME 100. BME 305 Biofluids 3 credits Prerequisite: One D.E.C. category E course The fundamentals of heat transfer, mass transfer, and 3 credits fluid mechanics in the context of physiological sys- BME 430 Engineering Approaches to Drug tems. Techniques for formulating and solving biofluid and Gene Delivery and mass transfer problems with emphasis on the spe- BME 212 Biomedical Engineering Introduction to the application of engineering princi- Research Fundamentals cial features and the different scales encountered in physiological systems, from the organ and the tissue ples and biological considerations in designing drug Introduction to data collection and analysis in the con- level down to the molecular transport level. delivery systems for medical uses. The concept of bio- text of biophysical measurements commonly used by Prerequisites: AMS 361 and MEC 262 compatibility and its implications in formulating con- bioengineers. Statistical measures, hypothesis testing, Pre- or Corequisite: BIO 202 or 203 trolled release devices are illustrated. Emphasis on linear regression, and analysis of variance are intro- the use of biodegradable materials to design drug duced in an application-oriented manner. Data collec- 3 credits delivery systems for site-specific applications. tion methods using various instruments, A/D boards, Prerequisites: AMS 161 or MAT 132 or 142; BIO 202 or and PCs as well as LabView, a powerful data collection BME 313 Bioinstrumentation 203; BME 304 computer package. Not for credit in addition to the Basic concepts of biomedical instrumentation and 3 credits discontinued BME 309. medical devices with a focus on the virtual instrumen- Prerequisites: BME 100 and MEC 260 tation in biomedical engineering using the latest com- BME 440 Biomedical Engineering Design puter technology. Topics include basic sensors in bio- Pre- or Corequisite: BIO 202 or 203 Introduction to product development from the per- 3 credits medical engineering, biological signal measurement, conditioning, digitizing, and analysis. Advanced appli- spective of solving biomedical, biotechnological, environmental, and ergonomic problems. Teamwork BME 300 Writing in Biomedical cations of LabView, a graphics programming tool for virtual instrumentation. Helps students develop skills in design, establishing customer needs, writing Engineering to build virtual instrumentation for laboratory specifications, and legal and financial issues are cov- See requirements for the major in Biomedical research and prototyping medical devices. ered in the context of design as a decision-based Engineering, upper-division writing requirement. Prerequisite: BME 212 process. A semester-long team design project fol- lows and provides the opportunity to apply concepts Prerequisites: WRT 102; U3 or U4 standing; BME 3 credits major covered in class. Prerequisites: BME major; U4 standing; BME 301 and Corequisite: Any 300-level BME course BME 353 Biomaterials: Manufacture, S/U grading 305 Properties, and Applications 3 credits BME 301 Bioelectricity The engineering characteristics of materials, includ- ing metals, ceramics, polymers, composites, coatings, Theoretical concepts and experimental approaches BME 441 Senior Design Project in and adhesives, that are used in the human body. Biomedical Engineering used to characterize electric phenomena that arise in Emphasizes the need of materials that are considered live cells and tissues. Topics include excitable mem- for implants to meet the material requirements speci- Formulation of optimal design problems in biomedical branes and action potential generation, cable theory, fied for the device application (e.g., strength, modu- and physiological settings. Introduces optimization equivalent dipoles and volume conductor fields, bio- lus, fatigue and corrosion resistance, conductivity) techniques for engineering design and modeling for electric measurements, electrodes and electric stimu- and to be compatible with the biological environment compact and rapid optimization of realistic biomedical lation of cells and tissues. (e.g., nontoxic, noncarcinogenic, resistant to blood engineering problems. Necessary conditions for con- Prerequisites: ESE 271; ESG 111 (or CSE 130 or ESE clotting if in the cardiovascular system). This course is strained local optimum with special consideration for 124 or MEC 111 or MEC 112); BIO 202 or 203; BME offered as both ESM 353 and BME 353. the constraints in which the product designed should 212 Prerequisite: ESG 332 function in terms of the settings (corporal, ex-corpo- 3 credits ral, biological, etc.) and the safety considerations 3 credits involved which are unique to biomedical engineering. Students carry out the detailed design of projects cho- BME 303 Biomechanics BME 381 Nanofabrication in Biomedical Illuminates the principles of mechanics and dynam- sen early in the semester. A final design report is ics that apply to living organisms, from cells to Applications required. humans to sequoia trees. The behavior of organisms Theory and applications of nanofabrication. Reviews Prerequisite: BME 440 is examined to observe how they are constrained by aspects of nanomachines in nature with special atten- 3 credits the physical properties of biological materials. tion to the role of self-lubrication, intracellular or inter- Locomotion strategies (or the lack thereof) are inves- stitial viscosity, and protein-guided adhesion. tigated for the forces and range of motions required Discusses current nanofabricated machines to per- and energy expenditures. Includes the relationship form the same tasks and considers the problems of between form and function to illustrate how form lubrication, compliance, and adhesion. Self-assembly 350 www.stonybrook.edu/ugbulletin Spring 2006: updates since Spring 2005 are in red COURSE DESCRIPTIONS BME 461 Biosystems Analysis Fundamentals of the linear time series analyses frame- work for modeling and mining biological data. Applications range from cardiorespiratory; renal blood
Load more

Recommended publications
  • Gene Therapy and Genetic Engineering: Frankenstein Is Still a Myth, but It Should Be Reread Periodically
    Indiana Law Journal Volume 48 Issue 4 Article 2 Summer 1973 Gene Therapy and Genetic Engineering: Frankenstein is Still a Myth, but it Should be Reread Periodically George A. Hudock Indiana University - Bloomington Follow this and additional works at: https://www.repository.law.indiana.edu/ilj Part of the Genetics and Genomics Commons Recommended Citation Hudock, George A. (1973) "Gene Therapy and Genetic Engineering: Frankenstein is Still a Myth, but it Should be Reread Periodically," Indiana Law Journal: Vol. 48 : Iss. 4 , Article 2. Available at: https://www.repository.law.indiana.edu/ilj/vol48/iss4/2 This Article is brought to you for free and open access by the Law School Journals at Digital Repository @ Maurer Law. It has been accepted for inclusion in Indiana Law Journal by an authorized editor of Digital Repository @ Maurer Law. For more information, please contact [email protected]. GENE THERAPY AND GENETIC ENGINEERING: FRANKENSTEIN IS STILL A MYTH, BUT IT SHOULD BE REREAD PERIODICALLY GEORGE A. HUDOCKt Biotechnology and the law are far removed from each other as disciplines of human intellect. Yet the law and my own discipline, genetics, have come together in many courtrooms concerning such matters as paternity, and they will continue to intersect with increasing frequency as the visions of 100 years ago become the reality of today. This article examines the implications of recent research for human genetic therapy and genetic engineering, and suggests some guidelines for legal regulation of genetic technology. The following discussion derives from three premises which I view as basic: (1) that which is currently possible in genetic engineering, and in fact has already been done, is generally underestimated; (2) what may be possible in the near future is quite commonly overesti- mated; (3) regulation of the application of genetic technology is possible and will not be overwhelmingly complicated.
    [Show full text]
  • Department of Biomedical Engineering (GRAD) 1
    Department of Biomedical Engineering (GRAD) 1 Candidates for the UNC–Chapel Hill/North Carolina State University DEPARTMENT OF BIOMEDICAL jointly issued degrees in biomedical engineering must have met the general requirements of The Graduate School of the University of North ENGINEERING (GRAD) Carolina at Chapel Hill or the North Carolina State University Graduate School. Contact Information *Currently matriculating* master’s students are required to take a Department of Biomedical Engineering comprehensive examination encompassing coursework and thesis Visit Program Website (http://www.bme.unc.edu) research. The master’s comprehensive exam may be either written or oral and is administered by the student’s advisory committee. Nancy L. Allbritton, Chair Doctoral students qualify for the Ph.D. degree by meeting grade Biomedical engineering is a dynamic field stressing the application requirements in their core courses and then advancing to written and of engineering techniques and mathematical analysis to biomedical oral preliminary exams before admission to candidacy. Details can be problems. Faculty research programs are key to the program, and they found on the department's website (https://bme.unc.edu/). Degree include five primary research directions: rehabilitation engineering, candidates in this program are expected to obtain experience working biomedical imaging, pharmacoengineering, regenerative medicine, and in a research laboratory during their residence and to demonstrate biomedical microdevices. The department offers graduate education in proficiency in research. The Ph.D. dissertation should be judged by the biomedical engineering leading to the master of science and doctor of graduate committee to be of publishable quality. philosophy degrees. Also, a joint graduate certificate in medical devices is offered.
    [Show full text]
  • BET Bionanotechnology and Advanced Biomanufacturing - 1B
    Course Package BET Bionanotechnology and Advanced Biomanufacturing - 1B Name module BET - Bionanotechnology and Advanced Biomanufacturing – 1B Educational programme MSc Biomedical Engineering Period Second quartile of the first semester (Block 1B) Study load 15 ECTS Coordinator J. Huttenhuis BET - Bionanotechnology and Advanced Biomanufacturing block 1A block 1B block 2A block 2B Biomedical Materials Engineering - 201400283 (5 EC) Nanomedicine - 201200220 (5 EC) Lab on a Chip - 191211120 (5 EC) Required preliminary knowledge: Followed the course 201600127 Introduction to Bionanotech & adv. Biomanufacturing in block 1A. A proven knowledge of Organic chemistry, polymer chemistry, biomaterials, cell-material interactions. 201400283 Biomedical Materials Engineering This course deals with the basic principles of tissue-biomaterial interactions, surface modification of biomaterials and polymer processing for regenerative medicine. Moreover, groups of 4-5 students draw up a research proposal that has to be defended during a plenary session. The modules are tentative and subject to change. Please check the website regularly. 201200220 Nanomedicine Nanomedicine is one of the most dynamic fields, which holds a high potential to make a huge impact on the medical science. Nanomedicine is in general defined as medical applications of nanotechnology. In recent years, nanotechnologies have been applied for drug delivery, imaging/diagnostics, biosensing, in vitro diagnostics, and tissue engineering. One of the largest areas for nanomedicine is the drug delivery/targeting. Conventional medicine, which are either administered orally or with injections, are not always successful for achieving the desired therapeutic effects but rather show high side effects. Therefore, novel drug delivery systems are highly crucial to develop, using which the drugs can be specially delivered at the targeted site or even to the specific cell types.
    [Show full text]
  • New Techniques of Genetic Engineering
    March 2016 New techniques of genetic engineering Why EU GMO law must be fully applied to the so-called ‘New Plant Breeding Techniques’ The European Commission is considering whether genetically modified organisms (GMOs) that have been produced through a range of new techniques should be excluded from the European Union’s GMO regulations. Biotechnology companies want to apply these techniques to engineer plants and animals for use in industrial food, biomass and biofuel production. They argue that these new methods to directly modify the genetic make-up of living organisms fall outside the scope of EU GMO regulations. This would mean that there is no risk assessment, labelling and monitoring of GM organisms produced by the new techniques and their derived products. The Commission has announced that it will present a legal analysis on the matter by the end of March 2016. The new GMOs present a real risk to the environment and human health. Legal analysis shows that they are covered by EU GMO law. If they were to escape EU regulations, any potential negative effects on food, feed or environmental safety would go unchecked. European consumers, farmers and breeders would have no way to avoid GMOs. The Commission should leave no doubt that all products of genetic engineering are subject to EU GMO law which requires rigorous risk assessment, detectability and labelling. 1 Which techniques are we talking about? The biotechnology industry and the European Commission use the term ‘New Plant Breeding Techniques’ to refer to a diverse set of genetic
    [Show full text]
  • Drawing the Line: Disability, Genetic Intervention and Bioethics
    laws Article Drawing the Line: Disability, Genetic Intervention and Bioethics Adam Conti Graduate student, Melbourne Law School, University of Melbourne, 185 Pelham St., Carlton, VIC 3053, Australia; [email protected] Received: 2 June 2017; Accepted: 10 July 2017; Published: 17 July 2017 Abstract: Meteoric scientific advances in genetic technologies with the potential for human gene editing intervention pose tremendous legal, medical, social, ethical and moral issues for society as a whole. Persons with disabilities in particular have a significant stake in determining how these technologies are governed at the international, domestic and individual levels in the future. However, the law cannot easily keep up with the rate of scientific progression. This paper aims to posit a methodology of reform, based on a core value of human dignity, as the optimal course of action to ensure that the interests of persons with disabilities, other possibly marginalised groups, and the scientific community, are balanced fairly. The paper critically analyses the current law and varying bioethical perspectives to ultimately conclude that a clear principled approach toward open discussion and consensus is of paramount importance to have any chance of devising an effective regulatory regime over human gene editing technology. Keywords: disability; human rights; genetics; gene editing; bioethics; governance; human dignity; eugenics; germline; Convention on the Rights of Persons with Disabilities The true good is in the different, not the same (Menand 2004). 1. Introduction Popular, professional and scholarly interest in genetics and their influence on human variability, behaviour and development has grown exponentially in recent years. In no small part has this interest been bolstered by mainstream media coverage of large-scale collaborative scientific initiatives like the Human Genome Project, which endeavoured to identify and map the human genome and determine the sequence of nucleotide base pairs that make up our DNA.
    [Show full text]
  • Genetic Engineering & Genetically Modified Organisms
    Genetic Engineering & Genetically Modified Organisms: Forming Informed Opinions By Smith, Lisa Scientific Theme(s): Science and Technology *Relationships among science, technology, and society Grade Level(s): 6-8 Lesson Duration: Designed for one 70 minute lesson Overview This lesson provides students an introduction to genetic engineering and genetically modified organisms, and raises student awareness of the potential Bias of availaBle information and the importance of forming informed, defendaBle opinions regarding controversial topics in science. The lesson was designed as an introduction for students to the genetic engineering and genetically modified organisms in preparation for a two-week research project exploring GMO topics, culminating with student presentations giving their opinions on the topics. Objectives Students will: 1. Define the term, ‘Biotechnology’. 2. Understand the difference Between selective Breeding and genetic engineering. 3. Identify different applications of genetic engineering, and recognize that all genetically engineered organisms are genetically modified organisms (GMOs). 4. Recognize Bias in print media, and to Be aware of the need to identify sources. 5. Understand the importance of forming informed, defendaBle opinions. Grade Level Expectations (GLEs) Addressed Science as Inquiry and Process [7] SA2.1 identifying and evaluating the sources used to support scientific statements Science and Technology [7] SE1.1 descriBing how puBlic policy affects the student’s life (e.g., puBlic waste disposal) [7] SE3.1 recognizing the effects of a past scientific discovery, invention, or scientific Breakthrough (e.g., DDT, internal comBustion engine) Required BacKground This lesson builds upon concepts covered in previous lessons on DNA, genes, and heredity. Students should have a solid understanding of the Basics of these concepts, including the idea that DNA is the “Blueprint” of life, that genes are coding regions of DNA, and that traits encoded By genes can Be inherited.
    [Show full text]
  • Biomedical Engineering Year 2 Course Description
    Making Opportunity Affordable in Texas: A Student-Centered Approach Tuning of Biomedical Engineering Texas Higher Education Coordinating Board Austin, Texas with grant support from Lumina Foundation for Education Completion date: May 2012 Tuning Oversight Council for Engineering and Science Biomedical Engineering Committee John C. Criscione, M.D., Ph.D. (Chair) Lennine Bashiri (Co-Chair) Associate Professor of Biomedical Engineering Instructor Department of Biomedical Engineering South Texas College Texas A&M University 3201 W. Pecan Blvd. 3120 TAMUS McAllen, TX 78502 College Station, TX 77843-3131 [email protected] [email protected] Leonidas Bleris, Ph.D. Ting Chen, Ph.D. Assistant Professor Instructional Assistant Professor,Research Assistant Professor, Department of Bioengineering Academic Advising Coordinator The University of Texas at Dallas Department of Biomedical Engineering 800 W. Campbell Rd Cullen College of Engineering Richardson, TX 75080 University of Houston [email protected] 3605 Cullen Blvd, Room 2018 Houston, TX 77204-5060 [email protected] Cheng-Jen "Charles" Chuong, Ph.D. Charlene Cole Professor Chair, Department of Life Sciences The University of Texas at Arlington Tarrant County Community College NE Arlington, TX 76019-0019 Department of Life Sciences [email protected] Hurst, TX 78054 [email protected] Harvinder Singh Gill, Ph.D. Joo L. Ong, Ph.D. Assistant Professor UTSA Distinguished Professor and Chair Department of Chemical Engineering The University of Texas at San Antonio Texas Tech University Department of Biomedical Engineering Lubbock, TX 79409-3121 San Antonio, TX 78249 [email protected] [email protected] Patrice Parsons, Ph.D. Chandeshwar Sharma, Ph.D. Professor Instructor, Coleman College for Health Sciences Grayson Community College Houston Community College Denison, TX 75020 Houston, TX 77030 [email protected] [email protected] James Tunnell, Ph.D.
    [Show full text]
  • Introducing Bionanotechnology Into Undergraduate Biomedical Engineering
    AC 2009-504: INTRODUCING BIONANOTECHNOLOGY INTO UNDERGRADUATE BIOMEDICAL ENGINEERING Aura Gimm, Duke University J. Aura Gimm is Assistant Professor of the Practice and Associated Director of Undergraduate Studies in the Department of Biomedical Engineering at Duke University. She teaches courses in biomaterials, thermodynamics/kinetics, engineering design, and a new course in bionanotechnology. Dr. Gimm received her S.B. in Chemical Engineering and Biology from MIT, and her Ph.D. in Bioengineering from UC-Berkeley. Page 14.802.1 Page © American Society for Engineering Education, 2009 Introducing Bionanotechnology in Undergraduate Biomedical Engineering Abstract As a part of the NSF-funded Nanotechnology Undergraduate Education Program, we have developed and implemented a new upper division elective course in Biomedical Engineering titled “Introduction to Bionanotechnology Engineering”. The pilot course included five hands- on “Nanolab” modules that guided students through specific aspects of nanomaterials and engineering design in addition to lecture topics such as scaling effects, quantum effects, electrical/optical properties at nanoscale, self-assembly, nanostructures, nanofabrication, biomotors, biological designing, biosensors, etc. Students also interacted with researchers currently working in the areas of nanomedicine, self-assembly, tribiology, and nanobiomaterials to learn first-hand the engineering and design challenges. The course culminated with research or design proposals and oral presentations that addressed specific engineering/design issues facing nanobiotechnology and/or nanomedicine. The assessment also included an exam (only first offering), laboratory write-ups, reading of research journal articles and analysis, and an essay on ethical/societal implications of nanotechnology, and summative questionnaire. The course exposed students to cross-disciplinary intersections that occur between biomedical engineering, materials science, chemistry, physics, and biology when working at the nanoscale.
    [Show full text]
  • Biomedical Engineering Department Medical
    BIOMEDICAL ENGINEERING DEPARTMENT MEDICAL ENGINEERING UNDERGRADUATE CURRICULUM 2014-15 (as of 5/10/13) The Medical Engineering Program is an option for HPME student only. This program is not accredited by the Engineering Accreditation Commission of ABET, http://www.abet.org. However, our Biomedical Engineering Program is accredited by this organization. Students entering this program are expected to have advanced work in high school such that they can be placed into MATH 230 and CHEM 171, or higher. All courses must be passed with a C grade or higher, and no courses within the 48 required for the degree may be taken P/N without approval. I. MATHEMATICS (4 courses) AP placement-Math 220, 224 MATH 230 Calculus MATH 234 Multiple Integration and Vector Calculus II. BASIC SCIENCES (4 courses) PHYSICS 135-2, 3 General Physics CHEM 171, 172 Accelerated Chemistry III. ENGINEERING ANALYSIS (4 courses) GEN ENG 205-1 Computational Methods and Linear Algebra GEN ENG 205-2 Linear Algebra and Mechanics GEN ENG 205-3 Dynamic System Modeling GEN ENG 205-4 Differential Equations IV. ENGINEERING DESIGN AND COMMUNICATION (3 courses) Speech 102, or 103 or Taken at Medical School IDEA 106-1, 2 Engineering Design and Communication (0.5 each) plus English 106-1,2 (0.5 each). V. BASIC ENGINEERING (5 courses) A. Thermodynamics - 1 course listed from those below BMD_ENG 250 Thermodynamics CHEM 342-1 Thermodynamics MECH ENG 220 Thermodynamics I B. Fluids and Solids - 2 courses as specified below BMD_ENG 271 Introduction to Biomechanics and BMD_ENG 270 Fluid Mechanics or MECH ENG 241 Fluid Mechanics I C.
    [Show full text]
  • Genetic Engineering (3500 Words)
    Genetic Engineering (3500 words) Biology Also known as: biotechnology, gene splicing, recombinant DNA technology Anatomy or system affected: All Specialties and related fields: Alternative medicine, biochemistry, biotechnology, dermatology, embryology, ethics, forensic medicine, genetics, pharmacology, preventive medicine Definition: Genetic engineering, recombinant DNA technology and biotechnology – the buzz words you may have heard often on radio or TV, or read about in featured articles in newspapers or popular magazines. It is a set of techniques that are used to achieve one or more of three goals: to reveal the complex processes of how genes are inherited and expressed, to provide better understanding and effective treatment for various diseases, (particularly genetic disorders) and to generate economic benefits which include improved plants and animals for agriculture, and efficient production of valuable biopharmaceuticals. The characteristics of genetic engineering possess both vast promise and potential threat to human kind. It is an understatement to say that genetic engineering will revolutionize the medicine and agriculture in the 21st future. As this technology unleashes its power to impact our daily life, it will also bring challenges to our ethical system and religious beliefs. Key terms: GENETIC ENGINEERING: the collection of a wide array of techniques that alter the genetic constitution of cells or individuals by selective removal, insertion, or modification of individual genes or gene sets GENE CLONING: the development
    [Show full text]
  • Engineering Solutions for Health: Biomedical Engineering Research Strategy March 2015
    Engineering Solutions for Health: Biomedical Engineering Research Strategy March 2015 Biomedical engineering is the application of engineering tools and approaches to advance knowledge and solve problems in animal and human biology, medicine and health care. Engineering Solutions for Health: Biomedical Engineering Research Strategy Biomedical engineering has dramatically advanced health care and health- related research over the past half-century for both human and animal populations, and will have an even greater influence in the future. High- quality health care is the foundation of a healthy society: health is at the core of quality of life and also drives social and economic development. Biomedical engineering makes important differences every day to individuals by extending their lives, ensuring the safety of their food and water supplies, improving their quality of life, promoting independence, and providing more effective options for front-line health care professionals. The University of Calgary has a strong track record This strategy will target health problems with of great accomplishments in biomedical engineering, the highest burden in terms of decreased quality based on making significant investments in this area of life, financial cost, mortality and morbidity to build a solid foundation of truly interdisciplinary — particularly cardiovascular disease, cancer, research and training. Engineering Solutions for injuries, musculoskeletal diseases and neurological Health: Biomedical Engineering is one of the conditions. Biomedical
    [Show full text]
  • The Moral Dilemma of Genetically Modified Foods (Gmos)
    Fordham University Masthead Logo DigitalResearch@Fordham Student Theses 2001-2013 Environmental Studies 2005 The orM al Dilemma of Genetically Modified Foods (GMOs) Anamarie Beluch Follow this and additional works at: https://fordham.bepress.com/environ_theses Part of the Environmental Sciences Commons Recommended Citation Beluch, Anamarie, "The orM al Dilemma of Genetically Modified Foods (GMOs)" (2005). Student Theses 2001-2013. 72. https://fordham.bepress.com/environ_theses/72 This is brought to you for free and open access by the Environmental Studies at DigitalResearch@Fordham. It has been accepted for inclusion in Student Theses 2001-2013 by an authorized administrator of DigitalResearch@Fordham. For more information, please contact [email protected]. The Moral Dilemma of Genetically Modified Foods (GMOs) By Anamarie Beluch Genetically modified (GM) foods are foods that are produced from genetically modified organisms (GMO) that have had their DNA altered through genetic engineering. The process of producing a GMO used for genetically modified foods involve taking DNA from one organism, modifying it in a laboratory, and then inserting it into the target organism's genome to produce new and useful genotypes or phenotypes. These techniques are generally known as recombinant DNA technology. In recombinant DNA technology, DNA molecules from different sources are combined in vitro into one molecule to create a new gene. This DNA is then transferred into an organism and causes the expression of modified or novel traits. Such GMOs are generally referred to as transgenic, which means pertaining to or containing a gene or genes from another species. There are other methods of producing a GMO, which include increasing or decreasing the number of copies of a gene already present in the target organism, silencing or removing a particular gene, or modifying the position of a gene within the genome.
    [Show full text]